Rights and permissions
About this article
Cite this article
Rofecoxib more cost effective than NSAIDs for osteoarthritis. Pharmacoecon. Outcomes News 332, 5 (2001). https://doi.org/10.1007/BF03269614
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03269614